Literature DB >> 12948019

Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium.

Matthew D Troutman1, Dhiren R Thakker.   

Abstract

PURPOSE: The purpose of this work was to elucidate the asymmetric effect of P-gp on modulation of absorptive and secretory transport of compounds across polarized epithelium, to develop experimental parameters to quantify P-gp-mediated modulation of absorptive and secretory transport, and to elucidate how P-gp-mediated modulation of transport is affected by passive diffusion properties, interaction of the substrate with P-gp, and P-gp expression.
METHODS: The permeability of a set of P-gp substrates was determined in absorptive and secretory directions in Madine-Darby Canine kidney (MDCK), Caco-2, and MDR-MDCK monolayers. The transport was also determined in the presence of GW918, a non-competitive P-gp inhibitor, to quantify the permeability without the influence of P-gp. From these two experimental permeability values in each direction, two new parameters, absorptive quotient (AQ) and the secretory quotient (SQ), were defined to express the functional activity of P-gp during absorptive and secretory transport, respectively. Western blot analysis was used to quantify P-gp expression in these monolayers and in normal human intestinal.
RESULTS: P-gp expression in Caco-2 and MDR-MDCK monolayers was comparable to that in normal intestine, and much less in MDCK cells. For all models, the substrates encompassed a wide range of apparent permeability due to passive diffusion (PPD). The parameters AQ and SQ, calculated for all compounds, assessed the attenuation in absorptive and enhancement of secretory transport, respectively, normalized to the permeability due to passive diffusion. Analysis of these parameters showed that 1) P-gp affected absorptive and secretory transport differentially and 2) compounds could be stratified into distinct groups with respect to the modulation of their absorptive and secretory transport by P-gp. Compounds could be identified whose absorptive transport was either strongly affected or poorly affected by changes in P-gp expression. For certain compounds, AQ values showed parabolic relationship with respect to passive diffusivity, and for others AQ was unaffected by changes in passive diffusivity.
CONCLUSIONS: The relationship between attenuation of absorptive transport and enhancement of secretory transport of compounds by P-gp is asymmetric, and different for different sets of compounds. The relationship between attenuation of absorption by P-gp and passive diffusivity of compounds, their interaction potential with P-gp, and levels of P-gp expression is complex; however, compounds can be classified into sets based on these relationships. A classification system that describes the functional activity of P-gp with respect to modulation of absorptive and secretory transport was developed from these results.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12948019     DOI: 10.1023/a:1025001131513

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  57 in total

1.  Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein.

Authors:  R B Kim; C Wandel; B Leake; M Cvetkovic; M F Fromm; P J Dempsey; M M Roden; F Belas; A K Chaudhary; D M Roden; A J Wood; G R Wilkinson
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

2.  Increased systemic toxicity of sarcoma chemotherapy due to combination with the P-glycoprotein inhibitor cyclosporin.

Authors:  J G Theis; H S Chan; M L Greenberg; D Malkin; V Karaskov; I Moncica; G Koren; J Doyle
Journal:  Int J Clin Pharmacol Ther       Date:  1998-02       Impact factor: 1.366

3.  Epithelial polarity, villin expression, and enterocytic differentiation of cultured human colon carcinoma cells: a survey of twenty cell lines.

Authors:  I Chantret; A Barbat; E Dussaulx; M G Brattain; A Zweibaum
Journal:  Cancer Res       Date:  1988-04-01       Impact factor: 12.701

4.  Identification of a novel route of extraction of sirolimus in human small intestine: roles of metabolism and secretion.

Authors:  Mary F Paine; Louis Y Leung; H K Lim; Kecheng Liao; Aram Oganesian; Mei-Yi Zhang; Kenneth E Thummel; Paul B Watkins
Journal:  J Pharmacol Exp Ther       Date:  2002-04       Impact factor: 4.030

5.  Saturable transport of H2-antagonists ranitidine and famotidine across Caco-2 cell monolayers.

Authors:  K Lee; D R Thakker
Journal:  J Pharm Sci       Date:  1999-07       Impact factor: 3.534

6.  Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.

Authors:  P F Augustijns; T P Bradshaw; L S Gan; R W Hendren; D R Thakker
Journal:  Biochem Biophys Res Commun       Date:  1993-12-15       Impact factor: 3.575

7.  Simulated intestinal fluid as transport medium in the Caco-2 cell culture model.

Authors:  F Ingels; S Deferme; E Destexhe; M Oth; G Van den Mooter; P Augustijns
Journal:  Int J Pharm       Date:  2002-01-31       Impact factor: 5.875

8.  P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.

Authors:  H Spahn-Langguth; G Baktir; A Radschuweit; A Okyar; B Terhaag; P Ader; A Hanafy; P Langguth
Journal:  Int J Clin Pharmacol Ther       Date:  1998-01       Impact factor: 1.366

9.  Drug binding sites on P-glycoprotein are altered by ATP binding prior to nucleotide hydrolysis.

Authors:  C Martin; G Berridge; P Mistry; C Higgins; P Charlton; R Callaghan
Journal:  Biochemistry       Date:  2000-10-03       Impact factor: 3.162

10.  In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

Authors:  F Hyafil; C Vergely; P Du Vignaud; T Grand-Perret
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

View more
  34 in total

Review 1.  Improving the prediction of the brain disposition for orally administered drugs using BDDCS.

Authors:  Fabio Broccatelli; Caroline A Larregieu; Gabriele Cruciani; Tudor I Oprea; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2011-12-21       Impact factor: 15.470

Review 2.  Coexistence of passive and carrier-mediated processes in drug transport.

Authors:  Kiyohiko Sugano; Manfred Kansy; Per Artursson; Alex Avdeef; Stefanie Bendels; Li Di; Gerhard F Ecker; Bernard Faller; Holger Fischer; Grégori Gerebtzoff; Hans Lennernaes; Frank Senner
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

3.  Urea-based inhibitors of Trypanosoma brucei methionyl-tRNA synthetase: selectivity and in vivo characterization.

Authors:  Sayaka Shibata; J Robert Gillespie; Ranae M Ranade; Cho Yeow Koh; Jessica E Kim; Joy U Laydbak; Frank H Zucker; Wim G J Hol; Christophe L M J Verlinde; Frederick S Buckner; Erkang Fan
Journal:  J Med Chem       Date:  2012-07-11       Impact factor: 7.446

4.  The elementary mass action rate constants of P-gp transport for a confluent monolayer of MDCKII-hMDR1 cells.

Authors:  Thuy Thanh Tran; Aditya Mittal; Tanya Aldinger; Joseph W Polli; Andrew Ayrton; Harma Ellens; Joe Bentz
Journal:  Biophys J       Date:  2004-10-22       Impact factor: 4.033

5.  Metabolic and efflux properties of Caco-2 cells stably transfected with nuclear receptors.

Authors:  Timo Korjamo; Jukka Mönkkönen; Jouko Uusitalo; Miia Turpeinen; Olavi Pelkonen; Paavo Honkakoski
Journal:  Pharm Res       Date:  2006-08-09       Impact factor: 4.200

Review 6.  Mechanistic approaches to predicting oral drug absorption.

Authors:  Weili Huang; Sau Lawrence Lee; Lawrence X Yu
Journal:  AAPS J       Date:  2009-04-21       Impact factor: 4.009

7.  Herb-drug interactions: challenges and opportunities for improved predictions.

Authors:  Scott J Brantley; Aneesh A Argikar; Yvonne S Lin; Swati Nagar; Mary F Paine
Journal:  Drug Metab Dispos       Date:  2013-12-11       Impact factor: 3.922

8.  Synthesis and evaluation of analogs of 5'-(((Z)-4-amino-2-butenyl)methylamino)-5'-deoxyadenosine (MDL 73811, or AbeAdo) - An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity.

Authors:  Anthony J Brockway; Oleg A Volkov; Casey C Cosner; Karen S MacMillan; Stephen A Wring; Thomas E Richardson; Michael Peel; Margaret A Phillips; Jef K De Brabander
Journal:  Bioorg Med Chem       Date:  2017-08-03       Impact factor: 3.641

9.  Transport and metabolism of some cationic ubiquinone antioxidants (MitoQn) in Caco-2 cell monolayers.

Authors:  Yan Li; J Paul Fawcett; Hu Zhang; Ian G Tucker
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2008 Oct-Dec       Impact factor: 2.441

10.  Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers.

Authors:  H M Faessel; A H Burstein; M D Troutman; S A Willavize; K D Rohrbacher; D J Clark
Journal:  Eur J Clin Pharmacol       Date:  2008-07-26       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.